secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2025-09-25T23:59:59+00:00
Accession:  0001728117-25-000076
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio issues 2.5M shares for option to acquire Respira Therapeutics
--------------------------------------------------------------------------

- Issued 2,500,000 shares to Prana Bio on Sept 24, 2025 as consideration for option to acquire Respira via merger.
- Option exercisable until Dec 31, 2027 or earlier upon completion of certain Respira development activities.
- May issue up to 1.5M additional shares upon exercise, plus up to ~6.7M shares on regulatory and sales milestones.
- Shares issued in reliance on Section 4(a)(2) exemption from registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811725000076/0001728117-25-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811725000076/goss-20250924.htm
  HTML page:      https://secwatch.observer/filing/0001728117-25-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer